AIM: To characterize the clinical indications of females (<15 years old) undergoing ovarian tissue cryopreservation (OTC) through the Oncofertility Consortium's National Physicians Cooperative (OC-NPC). PATIENTS & METHODS: The clinical indications of 114 females who underwent OTC were classified, and their incidence was compared with childhood cancer databases. RESULTS: Leukemias/myeloproliferative diseases/myelodysplastic diseases and hemoglobinopathies were the most prevalent oncologic and nononcologic indications for OTC, respectively. The frequencies of malignant bone tumors and soft tissue and other extraosseous sarcomas were higher in the OC-NPC cohort relative to the general population, while CNS/intracranial/intraspinal neoplasms, retinoblastoma and hepatic tumors were lower. CONCLUSION: Those opting for OTC through the OC-NPC are at highest fertility risk, indicating that the appropriate patient populations are being identified. [Formula: see text].
AIM: To characterize the clinical indications of females (<15 years old) undergoing ovarian tissue cryopreservation (OTC) through the Oncofertility Consortium's National Physicians Cooperative (OC-NPC). PATIENTS & METHODS: The clinical indications of 114 females who underwent OTC were classified, and their incidence was compared with childhood cancer databases. RESULTS:Leukemias/myeloproliferative diseases/myelodysplastic diseases and hemoglobinopathies were the most prevalent oncologic and nononcologic indications for OTC, respectively. The frequencies of malignant bone tumors and soft tissue and other extraosseous sarcomas were higher in the OC-NPC cohort relative to the general population, while CNS/intracranial/intraspinal neoplasms, retinoblastoma and hepatic tumors were lower. CONCLUSION: Those opting for OTC through the OC-NPC are at highest fertility risk, indicating that the appropriate patient populations are being identified. [Formula: see text].
Authors: R Abir; I Ben-Aharon; R Garor; I Yaniv; S Ash; S M Stemmer; A Ben-Haroush; E Freud; D Kravarusic; O Sapir; B Fisch Journal: Hum Reprod Date: 2016-02-04 Impact factor: 6.918
Authors: Natalie Quan; Jamie N Mara; Allison R Grover; Mary Ellen Pavone; Francesca E Duncan Journal: Tissue Eng Part A Date: 2020-06-26 Impact factor: 3.845
Authors: Sharrόn L Manuel; Molly B Moravek; Rafael Confino; Kristin N Smith; Angela K Lawson; Susan C Klock; Mary Ellen Pavone Journal: J Assist Reprod Genet Date: 2019-12-11 Impact factor: 3.412
Authors: James R Day; Anu David; Catherine Long; Grace G Bushnell; Teresa K Woodruff; Lonnie D Shea; Ariella Shikanov Journal: Regen Med Front Date: 2019-09-16
Authors: Brigid M Smith; Francesca E Duncan; Lauren Ataman; Kristin Smith; Gwendolyn P Quinn; R Jeffrey Chang; Courtney Finlayson; Kyle Orwig; Hanna Valli-Pulaski; Molly B Moravek; Mary B Zelinski; H Irene Su; Wendy Vitek; James F Smith; Jacqueline S Jeruss; Clarisa Gracia; Christos Coutifaris; Divya Shah; Leena Nahata; Veronica Gomez-Lobo; Leslie Coker Appiah; Robert E Brannigan; Valerie Gillis; William Gradishar; Asma Javed; Alice S Rhoton-Vlasak; Laxmi A Kondapalli; Evelyn Neuber; Jill P Ginsberg; Charles H Muller; Jennifer Hirshfeld-Cytron; William H Kutteh; Steven R Lindheim; Brooke Cherven; Lillian R Meacham; Pooja Rao; Lilibeth Torno; Leonard S Sender; Susan T Vadaparampil; Jodi L Skiles; Tara Schafer-Kalkhoff; Oliva J Frias; Julia Byrne; Lynn M Westphal; Danny J Schust; James L Klosky; Kate A McCracken; Alison Ting; Zaraq Khan; Candace Granberg; Barbara Lockart; Bert Scoccia; Monica M Laronda; Jennifer E Mersereau; Courtney Marsh; Mary Ellen Pavone; Teresa K Woodruff Journal: Future Oncol Date: 2018-11-26 Impact factor: 3.404
Authors: Atsuko Kusuhara; Elnur Babayev; Luhan T Zhou; Vijay P Singh; Jennifer L Gerton; Francesca E Duncan Journal: Front Cell Dev Biol Date: 2021-06-16